Get the Stockscreener App
0.245
32.43%
-0.1176
After Hours:
.25
0.005
+2.04%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Prophase Labs Inc stock is traded at $0.245, with a volume of 909.58K.
It is down -32.43% in the last 24 hours and down -81.15% over the past month.
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.
See More
Previous Close:
$0.3626
Open:
$0.2701
24h Volume:
909.58K
Relative Volume:
0.93
Market Cap:
$1.03M
Revenue:
$7.33M
Net Income/Loss:
$-21.20M
P/E Ratio:
-0.268
EPS:
-0.9143
Net Cash Flow:
$-12.68M
1W Performance:
-45.95%
1M Performance:
-81.15%
6M Performance:
-94.15%
1Y Performance:
-96.64%
1-Day Range:
$0.24
$0.3449
1-Week Range:
$0.24
$0.4725
52-Week Range:
$0.24
$7.80
Prophase Labs Inc Stock (PRPH) Company Profile
Name
Prophase Labs Inc
Sector
Industry
Phone
(215) 345-0919
Address
711 STEWART AVE, SUITE 200, NEW YORK, PA
Compare PRPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.245 | 1.52M | 7.33M | -21.20M | -12.68M | -0.9143 |
|
TMO
Thermo Fisher Scientific Inc
|
620.72 | 229.63B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
236.59 | 166.25B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
706.83 | 54.48B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
147.60 | 40.52B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
240.53 | 39.95B | 15.90B | 1.28B | 2.21B | 7.2842 |
Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-20-21 | Initiated | H.C. Wainwright | Buy |
| Oct-13-21 | Downgrade | Dawson James | Buy → Neutral |
| Jan-20-21 | Initiated | Dawson James | Buy |
Prophase Labs Inc Stock (PRPH) Latest News
ProPhase Labs, Inc.(NasdaqCM: PRPH) dropped from S&P TMI Index - marketscreener.com
How one lab swapped $3.3M of debt for shares, jolting its stock price - Stock Titan
MSN Money - MSN
ProPhase Labs, Inc. (NASDAQ:PRPH) Q4 2024 Earnings Call Transcript - MSN
ProPhase Labs faces Nasdaq delisting, plans appeal, OTC move - TipRanks
ProPhase Labs Received Notice of Delisting - TradingView — Track All Markets
ProPhase Labs Stock Hits 52-Week Low at $0.56 Amid Market Struggles - MSN
ProPhase Labs FY 2024 Earnings Preview - MSN
ProPhase Labs (PRPH) Stock Price, Quote, News & History - Benzinga
ProPhase Labs Inc. (NASDAQ: PRPH)Share Price - intelligentinvestor.com.au
Tranche Update on ProPhase Labs, Inc.'s Equity Buyback Plan announced on March 15, 2023. - marketscreener.com
ProPhase Labs signs non-binding LOI for proposed reverse merger with ABL - MSN
ProPhase Labs (PRPH) Stock News: Reverse Merger LOI With ABL, 1-for-10 Reverse Split Takes Effect Dec. 22, 2025 - ts2.tech
ProPhase Labs jumps as it signs LOI for reverse merger with Advanced Biological Laboratories - MSN
ProPhase Labs Earnings Notes - Trefis
ProPhase Labs announces proposed reverse merger with ABL - MSN
ProPhase Labs trading halted, news pending - MSN
ProPhase Labs Announces Proposed Reverse Merger with ABL - TipRanks
ProPhase Labs and ABL announce reverse merger plans By Investing.com - Investing.com Nigeria
ProPhase Labs files replacement legal opinion with new counsel By Investing.com - Investing.com Nigeria
ProPhase Labs files replacement legal opinion with new counsel - Investing.com
PRPH: Reverse merger LOI, $50M receivables recovery, and BE-Smart test commercialization advance - TradingView — Track All Markets
ProPhase Labs announces LOI for reverse merger with Advanced Biological - Proactive financial news
Will ProPhase Labs Inc. stock outperform Nasdaq index2025 AllTime Highs & Weekly High Return Stock Opportunities - DonanımHaber
ProPhase Labs stock soars after announcing reverse merger with ABL By Investing.com - Investing.com Nigeria
ProPhase Labs (PRPH) Surges on Proposed Reverse Merger with ABL - GuruFocus
ProPhase Labs stock soars after announcing reverse merger with ABL - Investing.com
PRPH: Proposed reverse merger gives ABL majority control and delivers near-term value to shareholders - TradingView — Track All Markets
ProPhase Labs, Advanced Biological Laboratories Sign Letter of Intent for Reverse Merger - marketscreener.com
ProPhase Labs, Inc. to Declare A Special Cash Dividend - marketscreener.com
What risks investors should watch in ProPhase Labs Inc. stockMarket Movement Recap & Capital Efficiency Focused Ideas - DonanımHaber
Why Is Prophase Labs Stock (PRPH) Up Today? - TipRanks
How ProPhase Labs Inc. stock compares to market leadersWeekly Risk Summary & Reliable Intraday Trade Plans - Улправда
Advanced Biological Laboratories S.A. signed a non-binding letter of intent to acquire ProPhase Labs, Inc. in a reverse merger transaction. - marketscreener.com
ProPhase Labs (PRPH) Explores Reverse Merger with ABL - GuruFocus
ProPhase Labs signs non-binding LOI for proposed reverse merger with Advanced Biological Laboratories - marketscreener.com
ProPhase’s proposed ABL merger could mean cash payout for holders - Stock Titan
Trading Recap: Is ProPhase Labs Inc. stock a safe haven assetQuarterly Portfolio Summary & Real-Time Chart Breakout Alerts - DonanımHaber
ABL Diagnostics Informs the Market of a Non‑Binding Letter of Intent Between ABL S.A. and ProPhase Labs (Nasdaq: PRPH) for a Proposed Reverse Merger - Business Wire
ProPhase Labs Signs Non-Binding LOI for Proposed Reverse Merger with Advanced Biological Laboratories - Sahm
ProPhase Labs (NASDAQ: PRPH) sets 1-for-10 reverse stock split effective Dec. 22 - Stock Titan
Will ProPhase Labs Inc. stock remain a Wall Street favoriteWeekly Profit Analysis & Weekly Watchlist for Hot Stocks - Улправда
Prophase Labs Faces Unsealed Civil Action Disclosure - MSN
Prophase Labs Implements Reverse Stock Split - The Globe and Mail
ProPhase Labs Delays Q3 Filing Amid Reorganization - MSN
ProPhase Labs (NASDAQ: PRPH) completes 1-for-10 reverse stock split, 5.77M shares outstanding - Stock Titan
The growth track for ProPhase Labs Inc (PRPH) has changed recently - setenews.com
Is ProPhase Labs Inc. stock a buy in volatile marketsIPO Watch & Technical Entry and Exit Tips - Newser
Prophase Labs Inc Stock (PRPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):